View in EDS HTML Full Text PDF Full Text

Evaluation of NUN-004, a Novel Engineered Ephrin Antagonist, in Healthy Volunteers and Patients with Amyotrophic Lateral Sclerosis: A Phase I/Ib, Open-Label, Escalating Dose and Extended Access Study: NUN-004 in Patients with Amyotrophic Lateral Sclerosis: M. Gerometta et al

Saved in:
Bibliographic Details
Title: Evaluation of NUN-004, a Novel Engineered Ephrin Antagonist, in Healthy Volunteers and Patients with Amyotrophic Lateral Sclerosis: A Phase I/Ib, Open-Label, Escalating Dose and Extended Access Study: NUN-004 in Patients with Amyotrophic Lateral Sclerosis: M. Gerometta et al
Authors: Gerometta, Michael1 (AUTHOR) mike@biosensisconsulting.com, Henderson, Robert D.2 (AUTHOR), Friend, Richard3 (AUTHOR), Cooper, Leanne T.1 (AUTHOR), Zhao, Jing1 (AUTHOR), Boyd, Andrew W.4 (AUTHOR), Bartlett, Perry F.1 (AUTHOR)
Source: Clinical Drug Investigation. Jan2025, Vol. 45 Issue 1, p17-28.
Database: SPORTDiscus with Full Text
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: s3h
DbLabel: SPORTDiscus with Full Text
An: 182467181
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Evaluation of NUN-004, a Novel Engineered Ephrin Antagonist, in Healthy Volunteers and Patients with Amyotrophic Lateral Sclerosis: A Phase I/Ib, Open-Label, Escalating Dose and Extended Access Study: NUN-004 in Patients with Amyotrophic Lateral Sclerosis: M. Gerometta et al
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Gerometta%2C+Michael%22">Gerometta, Michael</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> mike@biosensisconsulting.com</i><br /><searchLink fieldCode="AR" term="%22Henderson%2C+Robert+D%2E%22">Henderson, Robert D.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Friend%2C+Richard%22">Friend, Richard</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Cooper%2C+Leanne+T%2E%22">Cooper, Leanne T.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zhao%2C+Jing%22">Zhao, Jing</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Boyd%2C+Andrew+W%2E%22">Boyd, Andrew W.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Bartlett%2C+Perry+F%2E%22">Bartlett, Perry F.</searchLink><relatesTo>1</relatesTo> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Clinical+Drug+Investigation%22">Clinical Drug Investigation</searchLink>. Jan2025, Vol. 45 Issue 1, p17-28.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=s3h&AN=182467181
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s40261-024-01410-x
    Languages:
      – Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 12
        StartPage: 17
    Titles:
      – TitleFull: Evaluation of NUN-004, a Novel Engineered Ephrin Antagonist, in Healthy Volunteers and Patients with Amyotrophic Lateral Sclerosis: A Phase I/Ib, Open-Label, Escalating Dose and Extended Access Study: NUN-004 in Patients with Amyotrophic Lateral Sclerosis: M. Gerometta et al
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Gerometta, Michael
      – PersonEntity:
          Name:
            NameFull: Henderson, Robert D.
      – PersonEntity:
          Name:
            NameFull: Friend, Richard
      – PersonEntity:
          Name:
            NameFull: Cooper, Leanne T.
      – PersonEntity:
          Name:
            NameFull: Zhao, Jing
      – PersonEntity:
          Name:
            NameFull: Boyd, Andrew W.
      – PersonEntity:
          Name:
            NameFull: Bartlett, Perry F.
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Text: Jan2025
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-print
              Value: 11732563
          Numbering:
            – Type: volume
              Value: 45
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Clinical Drug Investigation
              Type: main
ResultId 1